KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
153 hedge funds and large institutions have $1.66B invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 58 increasing their positions, 23 reducing their positions, and 34 closing their positions.
152% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 23
82% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 34
45% more capital invested
Capital invested by funds: $1.14B → $1.66B (+$516M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
27% more call options, than puts
Call options by funds: $36.8M | Put options by funds: $29M
21% more funds holding
Funds holding: 126 → 153 (+27)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIC
Water Island Capital
New York
|
+$44.7M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$32.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$32M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$25.3M |
| 5 |
TAL
TIG Advisors LLC
New York
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$190M |
| 2 |
O
OrbiMed
New York
|
-$47.5M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$40.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$29.5M |
| 5 |
Bank of New York Mellon
New York
|
-$24.9M |
KYTH Hedge Fund Activity: Q2 2015 in Review
153 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q2 2015, worth a combined $1.66B — up 45% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new KYTH positions and 34 closed out — a net gain of 28 holders — while 58 added to existing stakes and 23 trimmed.
The largest buyer was Water Island Capital, opening a new position worth an estimated $44.7M. The largest seller was Fidelity Investments, exiting entirely with an estimated $190M sold.
- 153 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q2 2015, up from 126 in Q1 2015.
- Funds reported $1.66B of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q2 2015, up 45% quarter-over-quarter.
- 62 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q2 2015 and 34 closed out, a net change of +28 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q2 2015 was Water Island Capital, an estimated $44.7M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q2 2015 was Fidelity Investments, an estimated $190M sold.
Based on aggregated 13F filings for Q2 2015.